MENU

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GLUE is expected to report earnings to fall 162.14% to 18 cents per share on March 13

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q4'24
Est.
$0.18
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.19
The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -46 cents. With 1.79M shares outstanding, the current market capitalization sits at 431.90M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-0.13%
RXRX - GLUE
49%
Loosely correlated
-4.30%
PRTA - GLUE
44%
Loosely correlated
+11.34%
CRSP - GLUE
44%
Loosely correlated
+0.88%
BEAM - GLUE
43%
Loosely correlated
-1.21%
RCKT - GLUE
42%
Loosely correlated
+1.36%
More